Albert Labs International Corp. Share Price
Equities
ABRT
CA0127841041
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | +50.00% | -25.00% | +50.00% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 2.73M 3.73M 227M |
---|---|---|---|---|---|
Net income 2021 | -1M -1.37M -83.38M | Net income 2022 | -7M -9.57M -584M | EV / Sales 2021 * | - |
Net cash position 2021 | 76.7K 105K 6.39M | Net cash position 2022 | 79.12K 108K 6.6M | EV / Sales 2022 | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-0.32
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.71% |
1 day | +50.00% | ||
1 week | -25.00% | ||
3 months | -25.00% | ||
Current year | +50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Ravinder Kang
BRD | Director/Board Member | 58 | - |
Date | Price | Change | Volume |
---|---|---|---|
25/24/25 | 0.015 | +50.00% | 2,000 |
24/24/24 | 0.01 | 0.00% | 509,000 |
22/24/22 | 0.01 | -50.00% | 1,043,000 |
End-of-day quote Canadian Securities Exchange, April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+50.00% | 815K | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ABRT Stock